Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospecive study in apulia region (ITALY), 2009-2017
Since 2006, some Italian Regions introduced the active offer of measles, mumps, rubella, and varicella (MMRV) vaccine for all newborns during the second years of life. In 2011, Italian Drug Authority (AIFA) recommended the discontinuation of the MMRV use for an increased risk of febrile seizures fol...
Saved in:
Main Authors: | Pasquale Stefanizzi (Author), Sara De Nitto (Author), Francesco Patano (Author), Francesco Paolo Bianchi (Author), Davide Ferorelli (Author), Paolo Stella (Author), Domenica Ancona (Author), Vito Bavaro (Author), Silvio Tafuri (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines
by: Paolo Bonanni, et al.
Published: (2020) -
Inadequate Measles, Mumps, Rubella, and Varicella Immunity Among Employees
by: Stephen Ezeji-Okoye, et al.
Published: (2021) -
Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context
by: Giacomo Casabona, et al.
Published: (2023) -
Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014-19
by: Pasquale Stefanizzi, et al.
Published: (2022) -
Vacinas contra varicela e vacina quádrupla viral Varicella vaccines and measles, mumps, rubella, and varicella vaccine
by: Lucia Ferro Bricks, et al.
Published: (2006)